Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling
(2025)
Journal Article
Yang, Y., Hao, C., Jiao, T., Yang, Z., Li, H., Zhang, Y., Zhang, W., Doherty, M., Sun, C., Yang, T., Li, J., Wu, J., Zhang, M., Wang, Y., Xie, D., Wang, T., Wang, N., Huang, X., Li, C., Gonzalez, F. J., …Lei, G. (2025). Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling. Science, 388(6742), Article eadt0548. https://doi.org/10.1126/science.adt0548
Whether a gut-joint axis exists to regulate osteoarthritis is unknown. In two independent cohorts, we identified altered microbial bile acid metabolism with reduced glycoursodeoxycholic acid (GUDCA) in osteoarthritis. Suppressing farnesoid X receptor... Read More about Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling.